Suppr超能文献

线粒体 NAD 控制核 ARTD1 诱导的 ADP-核糖基化。

Mitochondrial NAD Controls Nuclear ARTD1-Induced ADP-Ribosylation.

机构信息

Department of Molecular Mechanisms of Disease (DMMD), University of Zurich, 8057 Zurich, Switzerland; Life Science Zurich Graduate School, Molecular Life Science Ph.D. Program, University of Zurich, 8057 Zurich, Switzerland.

Department of Chemical Biology, Max Planck Institute for Medical Research, 69120 Heidelberg, Germany.

出版信息

Mol Cell. 2021 Jan 21;81(2):340-354.e5. doi: 10.1016/j.molcel.2020.12.034. Epub 2021 Jan 14.

Abstract

In addition to its role as an electron transporter, mitochondrial nicotinamide adenine dinucleotide (NAD) is an important co-factor for enzymatic reactions, including ADP-ribosylation. Although mitochondria harbor the most intra-cellular NAD, mitochondrial ADP-ribosylation remains poorly understood. Here we provide evidence for mitochondrial ADP-ribosylation, which was identified using various methodologies including immunofluorescence, western blot, and mass spectrometry. We show that mitochondrial ADP-ribosylation reversibly increases in response to respiratory chain inhibition. Conversely, HO-induced oxidative stress reciprocally induces nuclear and reduces mitochondrial ADP-ribosylation. Elevated mitochondrial ADP-ribosylation, in turn, dampens HO-triggered nuclear ADP-ribosylation and increases MMS-induced ARTD1 chromatin retention. Interestingly, co-treatment of cells with the mitochondrial uncoupler FCCP decreases PARP inhibitor efficacy. Together, our results suggest that mitochondrial ADP-ribosylation is a dynamic cellular process that impacts nuclear ADP-ribosylation and provide evidence for a NAD-mediated mitochondrial-nuclear crosstalk.

摘要

除了作为电子转运体的作用外,线粒体烟酰胺腺嘌呤二核苷酸(NAD)还是酶反应的重要辅酶,包括 ADP-核糖基化。尽管线粒体含有最多的细胞内 NAD,但线粒体 ADP-核糖基化仍然知之甚少。在这里,我们提供了线粒体 ADP-核糖基化的证据,这些证据是使用各种方法学鉴定的,包括免疫荧光、western blot 和质谱。我们表明,线粒体 ADP-核糖基化可对呼吸链抑制做出可逆反应。相反,HO 诱导的氧化应激反过来诱导核 ADP-核糖基化减少和线粒体 ADP-核糖基化减少。线粒体 ADP-核糖基化的升高反过来又抑制了 HO 触发的核 ADP-核糖基化,并增加了 MMS 诱导的 ARTD1 染色质保留。有趣的是,用线粒体解偶联剂 FCCP 共同处理细胞会降低 PARP 抑制剂的疗效。总之,我们的结果表明,线粒体 ADP-核糖基化是一种动态的细胞过程,会影响核 ADP-核糖基化,并为 NAD 介导的线粒体-核串扰提供证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a882/7837215/5732353db5c4/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验